Biomind Labs Inc.
BMND
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.40% | -138.77% | 599.42% | 83.73% | -13.91% |
| Total Depreciation and Amortization | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.59% | 82.25% | -383.33% | -154.49% | 37.09% |
| Change in Net Operating Assets | -1.06% | 2,620.00% | 79.91% | -127.59% | 1,260.00% |
| Cash from Operations | 3,840.00% | 100.49% | 7.56% | -340.87% | 78.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 51.79% | -28.09% | -13.10% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -- | -- | 67.06% | -34.66% | -13.10% |
| Foreign Exchange rate Adjustments | -3,880.00% | -106.25% | -78.61% | 276.42% | -643.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -200.00% |
| Net Change in Cash | -- | 100.00% | 56.71% | -73.68% | -159.64% |